CRISPR/Cas9-mediated generic protein tagging in mammalian cells
- PMID: 30797903
- DOI: 10.1016/j.ymeth.2019.02.018
CRISPR/Cas9-mediated generic protein tagging in mammalian cells
Abstract
Systematic protein localization and protein-protein interaction studies to characterize specific protein functions are most effectively performed using tag-based assays. Ideally, protein tags are introduced into a gene of interest by homologous recombination to ensure expression from endogenous control elements. However, inefficient homologous recombination makes this approach difficult in mammalian cells. Although gene targeting efficiency by homologous recombination increased dramatically with the development of designer endonuclease systems such as CRISPR/Cas9 capable of inducing DNA double-strand breaks with unprecedented accuracy, the strategies still require synthesis or cloning of homology templates for every single gene. Recent developments have shown that endogenous protein tagging can be achieved efficiently in a homology independent manner. Hence, combinations between CRISPR/Cas9 and generic tag-donor plasmids have been used successfully for targeted gene modifications in mammalian cells. Here, we developed a tool kit comprising a CRISPR/Cas9 expression vector with several EGFP encoding plasmids that should enable tagging of almost every protein expressed in mammalian cells. By performing protein-protein interaction and subcellular localization studies of mTORC1 signal transduction pathway-related proteins expressed in HEK293T cells, we show that tagged proteins faithfully reflect the behavior of their native counterparts under physiological conditions.
Keywords: CRISPR/Cas; EGFP; Protein tagging; Proteomics; mTORC1.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
CRISPR/Cas9-Mediated Gene Tagging: A Step-by-Step Protocol.Methods Mol Biol. 2019;1961:255-269. doi: 10.1007/978-1-4939-9170-9_16. Methods Mol Biol. 2019. PMID: 30912051
-
Tagging Proteins with Fluorescent Reporters Using the CRISPR/Cas9 System and Double-Stranded DNA Donors.Methods Mol Biol. 2021;2247:39-57. doi: 10.1007/978-1-0716-1126-5_3. Methods Mol Biol. 2021. PMID: 33301111
-
A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone.BMC Mol Biol. 2018 Mar 14;19(1):3. doi: 10.1186/s12867-018-0105-8. BMC Mol Biol. 2018. PMID: 29540148 Free PMC article.
-
[Research progress in the third-generation genomic editing technology - CRISPR/Cas9].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Oct;33(5):713-6. doi: 10.3760/cma.j.issn.1003-9406.2016.05.030. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016. PMID: 27577230 Review. Chinese.
-
Recent Advances in CRISPR/Cas9-Mediated Genome Editing in Dictyostelium.Cells. 2019 Jan 12;8(1):46. doi: 10.3390/cells8010046. Cells. 2019. PMID: 30642074 Free PMC article. Review.
Cited by
-
Selection-free endogenous tagging of cell lines by bicistronic co-expression of the surface antigen NGFR.MethodsX. 2022 Nov 18;9:101929. doi: 10.1016/j.mex.2022.101929. eCollection 2022. MethodsX. 2022. PMID: 36444289 Free PMC article.
-
Focal adhesion-related non-ciliary functions of CEP290.PLoS One. 2025 Jul 9;20(7):e0325921. doi: 10.1371/journal.pone.0325921. eCollection 2025. PLoS One. 2025. PMID: 40632733 Free PMC article.
-
CRISPR/Cas9 technology: applications in oocytes and early embryos.J Transl Med. 2023 Oct 24;21(1):746. doi: 10.1186/s12967-023-04610-9. J Transl Med. 2023. PMID: 37875936 Free PMC article. Review.
-
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.Cancer Discov. 2023 Aug 4;13(8):1862-1883. doi: 10.1158/2159-8290.CD-22-1401. Cancer Discov. 2023. PMID: 37141112 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials